1. Biotech IPO bonanza: Legend Biotech, Forma Therapeutics, Repare — COVID-19 could slow progress in reducing cancer death, NCI warns — ASCO 2020 news from Merck, AstraZeneca, Pfizer, more — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

HIV division

Discussion in 'Serono' started by anonymous, Jun 25, 2017 at 8:13 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Any insight on the HIV division? Is the product still necessary in today's treatment algorithm?
     

  2. anonymous

    anonymous Guest


    HIV division is not long for this world....the ones remaining better start looking elsewhere! More layoffs ahead.
     
  3. anonymous

    anonymous Guest

    Any job in pharma is like that, Einstein